According to the current analysis of Reports and Data, the global fertility testing market was valued at 403.7 million in 2018 and is expected to reach USD 702.3 million by the year 2026, at a CAGR of 7.1%. Fertility testing market is rising due to delay in pregnancy, and due to the late pregnancy cases, as after crossing the age of 30, female decreases the chance of conceiving and further till the age of 35, the chance of conceiving further declines. Due to this, there is a fewer number of eggs left in the ovaries, which leads to irregular or absence of a menstrual cycle, PCOS & POI further proceeds for infertility. Damaged sperm is the most common cause of male infertility. The factors driving the industry includes the rise in PCOS disorders, increasing primary ovarian insufficiency (POI) and low sperm motility.
Fertility kits are developed to check fertility in which mostly the ovulation test kits are used, for detecting luteinizing hormone (LH) level and sometimes even estrogen levels to predict the ovulation. These kits, however, do not provide exact information about ovulation. The luteinized unruptured follicle syndrome ovulation predictor fails to give proper results. Also, LH measurement predicts ovulation and cannot determine the date of ovulation or anovulation. The leading manufacturers in the industry are Clearblue (Swiss Precision Diagnostics GmbH), First Response, and Prestige. With the rise in importance of testing and development of ovulation monitors, a decline in the fertility rate globally among females, and easily accessible ovulation monitors are few other factors contributing to the market growth. As ovulation monitors are expensive and do not precisely confirm ovulation, these factors act as a restraint to the market.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2510
Further key findings from the report
Buy Now: https://www.reportsanddata.com/checkout-form/2510
For the purpose of this report, Reports and Data has segmented the fertility testing market on the basis of product, mode of purchase, type, application, distribution channel, end use and region:
Product Outlook (Revenue in Million USD; 2016–2026)
Mode of Purchase Outlook (Revenue in Million USD; 2016–2026)
Type Outlook (Revenue in Million USD; 2016–2026)
Application Outlook (Revenue in Million USD; 2016–2026)
Distribution Channel Outlook (Revenue in Million USD; 2016–2026)
End Use Outlook (Revenue in Million USD; 2016–2026)
Regional Outlook (Revenue in Million USD; 2016–2026)
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/fertility-testing-market
Table Of Content:
Chapter 1. Market Synopsis 1.1. Market Definition 1.2. Research Scope & Premise 1.3. Methodology 1.4. Market Estimation Technique Chapter 2. Executive Summary 2.1. Summary Snapshot, 2016 – 2026 Chapter 3. Indicative Metrics 3.1. Macro-Economic Indicators 3.1.1. Delaying of pregnancy 3.1.2. Infertility Issues 3.1.3. Increase in Healthcare Spending’s Chapter 4. Global Fertility Testing Segmentation & Impact Analysis 4.1. Global Fertility Testing Segmentation Analysis 4.2. Industrial Outlook 4.3. Market Indicators Analysis 4.3.1. Market Drivers Analysis 4.3.1.1. Rise in PCOS disorders
….
Chapter 12. Competitive Landscape 12.1. Market Revenue Share by Manufacturers 12.2. Mergers & Acquisitions 12.3. Strategy Benchmarking 12.3.1. Partnership & Agreement 12.3.2. New Product Development 12.3.3. Mergers & Acquisitions 12.3.4. Investment & Expansion 12.4. Vendor Landscape Chapter 13. Company Profiles 13.1. Advacare Pharma 13.1.1. Company Overview 13.1.2. Financial Insights 13.1.3. Products Offered 13.1.4. Strategic Initiatives 13.2. AVA 13.2.1. Company Overview 13.2.2. Financial Insights 13.2.3. Products Offered 13.2.4. Strategic Initiatives 13.3. Babystart 13.3.1. Company Overview 13.3.2. Financial Insights 13.3.3. Products Offered 13.3.4. Strategic Initiatives 13.4. Fertility Focus 13.4.1. Company Overview 13.4.2. Financial Insights 13.4.3. Products Offered 13.4.4. Strategic Initiatives 13.5. Geratherm Medical 13.5.1. Company Overview 13.5.2. Financial Insights 13.5.3. Products Offered 13.5.4. Strategic Initiatives 13.6. Hilin Life Products 13.6.1. Company Overview 13.6.2. Financial Insights 13.6.3. Products Offered 13.6.4. Strategic Initiatives Continue…
About Us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.
Media ContactCompany Name: Reports and DataContact Person: John WatsonEmail: Send EmailPhone: +1-212-710-1370Address:40 Wall St. 28th floor City: New York CityState: NY 10005Country: United StatesWebsite: https://www.reportsanddata.com/press-release/global-fertility-testing-market